Enter assignee name

% Expired Patents = 16.7

EPO Patents = 2

Trademarks = 2

Forward Citations = 31

Loading Chart...

5 inventors (with patents filed for the assignee):

Guoqing Paul Chen (5 out of 22 patents)

Changren Yan (3 out of 4 patents)

Paul Chen Guoqing (1 out of 1 patent)

4. Yan Changren (1 out of 1 patent)

5. Chen Monica (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 10730878 - Fused quinoline compounds as PI3K/mTOR inhibitors (2020-08-04),

2. 10544125 - Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts (2020-01-28),

3. 10100034 - Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts (2018-10-16),

4. 9783498 - Process for preparing the anti-tumor agent 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide and its crystalline (2017-10-10),

5. 9751859 - Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts (2017-09-05),

6. 8664244 - Compounds as c-Met kinase inhibitors (2014-03-04),

Advenchen Pharmaceuticals, LLC is a biopharmaceutical company focused on developing innovative therapies for various medical conditions. With a strong focus on research and development, we aim to improve patient outcomes and quality of life through the advancement of cutting-edge treatments. Our dedicated team of experts work tirelessly to bring novel drugs to market, addressing unmet medical needs and making a positive impact on global health.

Profile summary based on public USPTO records.